TN HB1328 | 2017-2018 | 110th General Assembly
Status
Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on February 9 2017 - 25% progression, died in chamber
Action: 2017-02-17 - Assigned to s/c Insurance and Banking Subcommittee
Text: Latest bill text (Draft #1) [PDF]
Status: Introduced on February 9 2017 - 25% progression, died in chamber
Action: 2017-02-17 - Assigned to s/c Insurance and Banking Subcommittee
Text: Latest bill text (Draft #1) [PDF]
Summary
As introduced, enacts the Prescription Drug Fair Pricing Act; requires studies and reports on or before January 15, 2018, by the commissioner of health concerning price gouging for essential generic drugs and the commissioner of commerce and insurance concerning price transparency for prescription drugs; requires reports to legislative committees. - Amends TCA Title 4; Title 53; Title 56; Title 63; Title 68 and Title 71.
Title
As introduced, enacts the Prescription Drug Fair Pricing Act; requires studies and reports on or before January 15, 2018, by the commissioner of health concerning price gouging for essential generic drugs and the commissioner of commerce and insurance concerning price transparency for prescription drugs; requires reports to legislative committees. - Amends TCA Title 4; Title 53; Title 56; Title 63; Title 68 and Title 71.
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2017-02-17 | House | Assigned to s/c Insurance and Banking Subcommittee |
| 2017-02-15 | House | P2C, ref. to Insurance and Banking Committee-- Health |
| 2017-02-13 | House | P1C. |
| 2017-02-09 | House | Intro. |
| 2017-02-09 | House | Filed for intro. |
Same As/Similar To
SB1420 (Crossfiled) 2017-02-13 - Passed on Second Consideration, refer to Senate Commerce and Labor Committee
